Aurobindo Pharma has informed that it attached the revised presentation that would be used in the investors / analysts call on Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025 to be held today, February 10, 2026 at 8.30 am. The revised presentation is also being uploaded to the following weblink of the Company. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/presentations.
The above information is a part of company’s filings submitted to BSE.
